Immune Thrombocytopenic Purpura after Recombinant Hepatitis B Vaccine: Retrospective Study of Seven Cases

By Neau Didier   Bonnet Fabrice   Michaud Maggy   Perel Yves   Longy-Boursier Maïté   Ragnaud Jean-Marie   Guillard Jean-Michel  

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 2, 1998-07 ,pp. : 115-118

Informa Healthcare

Access to resources Recommend Favorite

Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine

By Meriste Sirli   Lutsar Irja   Tamm Eda   Willems Paul  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 5, 2006-05 ,pp. : 350-356

Informa Healthcare

Access to resources Recommend Favorite

Fatal Interruption of a 3TC-containing Regimen in a HIV-infected Patient Due to Re-activation of Chronic Hepatitis B Virus Infection

By Sellier Pierre   Clevenbergh Philippe   Mazeron Marie-christine   Cazals-hatem Dominique   Evans John   Cervoni Jeanine   Badsi Esma   Bendenoun Marc   Diemer Myriam   Vincent Valerie   Caulin Charles   Bergmann Jean-francois  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 6-7, 2004-07 ,pp. : 533-535

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose propranolol regimen for infantile haemangioma

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 4, 2015-04 ,pp. : 419-424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis

By Takata Toshihiko   Aizawa Kazumasa   Shimizu Atsuyuki   Sakakibara Shiro   Watabe Hiroomi   Totsuka Kyoichi  

Journal of Infection and Chemotherapy, Vol. 10, Iss. 2, 2004-04 ,pp. : 76-85

Springer Publishing Company

Access to resources Recommend Favorite